{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:26:29Z","timestamp":1790828789432,"version":"4.1.0"},"reference-count":37,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2003,10,29]],"date-time":"2003-10-29T00:00:00Z","timestamp":1067385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsia"],"published-print":{"date-parts":[[2003,11]]},"abstract":"<jats:p><jats:bold>Summary:\u2002<\/jats:bold>  <jats:italic>Purpose:<\/jats:italic> We developed a new in vitro preparation of immature rats, in which intact corticohippocampal formations (CHFs) depleted in magnesium ions become progressively epileptic. The better to characterize this model, we examined the effects of 14 antiepileptic drugs (AEDs) currently used in clinical practice.<\/jats:p><jats:p> <jats:italic>Methods:<\/jats:italic> Recurrent ictal\u2010like seizures (ILEs, four per hour) were generated in intact CHFs of P7\u20138 rats, and extracellular recordings were performed in the hippocampus and neocortex. AEDs were applied at clinically relevant concentrations (at least two), during 30 min after the third ILE. Their ability to prevent or to delay the next ILE was examined.<\/jats:p><jats:p> <jats:italic>Results:<\/jats:italic> Valproic acid and benzodiazepines (clobazam and midazolam) but also phenobarbital and levetiracetam prevent the occurrence of seizures. In contrast, usual concentrations of carbamazepine (CBZ), phenytoin, vigabatrin, tiagabine, gabapentin, lamotrigine (LTG), topiramate, felbamate, and ethosuximide did not suppress ILEs. In addition, LTG and CBZ aggravate seizures in one third of the cases.<\/jats:p><jats:p> <jats:italic>Conclusions:<\/jats:italic> This intact in vitro preparation in immature animals appears to be quite resistant to most AEDs. Blockade of seizures was achieved with drugs acting mainly at the \u03b3\u2010aminobutyric acid (GABA)<jats:sub>A<\/jats:sub>\u2010receptor site but not with those that increase the amount of GABA. Drugs with a broad spectrum of activity are efficient but not those preferentially used in partial seizures or absences. We suggest that this preparation may correspond to a model of epilepsy with generalized convulsive seizures and could be helpful to develop new AEDs for refractory infantile epilepsies.<\/jats:p>","DOI":"10.1046\/j.1528-1157.2003.19503.x","type":"journal-article","created":{"date-parts":[[2003,11,6]],"date-time":"2003-11-06T14:58:29Z","timestamp":1068130709000},"page":"1365-1374","source":"Crossref","is-referenced-by-count":49,"title":["Effects of Antiepileptic Drugs on Refractory Seizures in the Intact Immature Corticohippocampal Formation In Vitro"],"prefix":"10.1111","volume":"44","author":[{"given":"Pascale Paule","family":"Quilichini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diab\u00e9","family":"Diabira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Chiron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Milh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehezkel","family":"Ben\u2010Ari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Gozlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,10,29]]},"reference":[{"issue":"4","key":"e_1_2_6_2_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1528-1167.2001.00002.x","article-title":"Animal models used in the screening of antiepileptic drugs","volume":"42","author":"Kupferberg H","year":"2001","journal-title":"Epilepsia"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(97)00035-X"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004691-199307000-00004"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199615060-00003"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1998.tb01268.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1998.tb01413.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2002.02143.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1987.57.3.869"},{"key":"e_1_2_6_10_2","volume-title":"Antiepileptic drugs","author":"Levy RH","year":"1995"},{"key":"e_1_2_6_11_2","first-page":"172","article-title":"[Serum concentration of anticonvulsants: practical guidelines for measuring and useful interpretation. Therapy Committee of the German Section of the International Epilepsy League]","volume":"70","author":"Froscher W","year":"1999","journal-title":"Nervenarzt"},{"key":"e_1_2_6_12_2","first-page":"1","volume-title":"Encyclop\u00e9die M\u00e9dico\u2010Chirurgicale.","author":"Dulac O","year":"1998"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199606133342407"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2001.41300.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2002.28501.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0387-7604(00)00116-9"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1998.tb07286.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(94)00067-7"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(00)00112-1"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(00)00420-9"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1999.81.1.399"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1006\/phrs.2000.0689"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1999.tb00920.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1996.tb15710.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(99)00628-7"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/hipo.1993.4500030712"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199707280-00042"},{"key":"e_1_2_6_28_2","first-page":"119","article-title":"Reduction of the frequency of occurrence of low magnesium induced field potentials in the hippocampus slice preparation of guinea pigs: a good screening tool for calcium antagonistic effects of anticonvulsant and antipsychotic drugs","volume":"10","author":"Grunze H","year":"1997","journal-title":"Magnes Res"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(96)00384-7"},{"key":"e_1_2_6_30_2","first-page":"1759","article-title":"Effects of felbamate on muscarinic and metabotropic\u2010glutamate agonist\u2010mediated responses and magnesium\u2010free or 4\u2010aminopyridine\u2010induced epileptiform activity in guinea pig olfactory cortex neurons in vitro","volume":"277","author":"Libri V","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(01)00122-X"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1999.tb02029.x"},{"key":"e_1_2_6_33_2","first-page":"1100","article-title":"Felbamate decreases synaptic transmission in the CA1 region of rat hippocampal slices","volume":"279","author":"Pugliese AM","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00005097"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.2000.tb02164.x"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1152\/jn.2001.86.2.596"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(91)91104-9"},{"key":"e_1_2_6_38_2","first-page":"821","volume-title":"The treatment of epilepsy: principles and practice","author":"Wyllie E","year":"2001"}],"container-title":["Epilepsia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1528-1157.2003.19503.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1528-1157.2003.19503.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T06:48:41Z","timestamp":1697179721000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1528-1157.2003.19503.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,29]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["10.1046\/j.1528-1157.2003.19503.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1528-1157.2003.19503.x","archive":["Portico"],"relation":{},"ISSN":["0013-9580","1528-1167"],"issn-type":[{"value":"0013-9580","type":"print"},{"value":"1528-1167","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,29]]}}}